
KayoThera
A nuclear target to revive anti-tumor immunity.
$8M Series A ·
Source: startupintros.com
Latest round on record: Series A, July 2023, amount undisclosed.
All 2 rounds ↓Signals
Website registeredApr 17, 2019 (7 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | undisclosed | — | fundraisingfox.com | |
| Series A | $8M | — | startupintros.com |
Timeline
- Website created
Founders and team
- MEMARK ESPOSITO CSO Co-Founder and Board Membersource: kayothera.com
- YKYIBIN KANG Chair, Scientific Advisory Board and Co-Foundersource: kayothera.com
Companies like KayoThera
VVerImmune$3.12M Seed · Sep 2023
NNormunity$75M Series B+ · Jan 2025
TTacalyx$12.88M Seed · Apr 2026
AA2 Biotherapeutics$80M Series B+ · Jan 2025
EElucent Medical$42.5M Series B+ · Apr 2024
33T Biosciences$40M Series A · Aug 2022
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/kayothera (get a free API key).